Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients.

Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.

Clinical Trials

Health Care

Medical Devices

Segal Trials

Scott D. Segal

Melissa Gianos

Giovanna Auerbach

Tabatha Cirgenski-Ruiz

Kadeeja Whyte

Danielle Recasens

Charlie Small

Rishi Kakar

Bonnie Segal

Kavoia Smalls

John R. Nocero Ph.D.

The Leadership Team at Segal Trials is responsible for setting the strategic direction and vision of the organization. This team, comprised of key executives including the Co-founders, Chief Medical Officer, and Chief Scientific Officer, oversees operational management, drives innovation in clinical research, ensures compliance with regulatory standards, and fosters collaboration among research sites. Their focus is on enhancing patient care and advancing medical treatments while maintaining the company's core values of quality and advocacy.

Leadership Team

Human Resources and Recruitment

Clinical Research Team

Leadership Team

About

Team members

Other teams at Segal Trials

Human Resources and Recruitment

Clinical Research Team